MedTrace Logo

Long-term Assessment of Rhône RéPPOP Care for Overweight and Obese Children.

NCT04360083 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2023-03-09

No results posted yet for this study

Summary

Childhood obesity is a major public health issue since it is a risk factor of adulthood obesity, cardiovascular disease, psychological disorders, and other chronic conditions.

RéPPOP is a two year personalized pathway for multidisciplinary care for overweight and obese children, close to patients' homes.

Short and medium-term assessments of Rhône RéPPOP care for overweight and obese children show encouraging results. Long-term assessment is needed to confirm these results.

The present study aims to assess the long-term efficiency of Rhône RéPPOP care for overweight and obese children by comparing BMI Z-scores at the start and the end of RéPPOP care to the current BMI. This data will be collected through a telephonic questionnaire by the scientific manager.

The study's secondary objectives are to evaluate patients and their families' lifestyle changes and to improve RéPPOP practices.

Conditions

  • Overweight, Childhood
  • Pediatric Obesity

Interventions

OTHER

Collected data from Rhône RéPPOP database

BMI Z-scores at the start and the end of RéPPOP care programs.

OTHER

telephonic questionnaire

Collected data though the telephonic questionnaire : current declared BMI Z-score.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • Marc NICOLINO, MD · Hospices Civils de Lyon, Endocrino-pediatric service, HFME

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2021-12-07
Completion
2021-12-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04360083 on ClinicalTrials.gov